SGLT2 Inhibitors and Heart Failure Outcomes in Different Patient Populations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations
Eur Heart J 2021 Oct 30;[EPub Ahead of Print], J Butler, SD Anker, G Filippatos, MS Usman, JP Ferreira, F Zannad, M PackerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.